Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

NCT00278954 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Primary Immunodeficiency
Common Variable Hypogammaglobulinemia
X-linked Hypogammaglobulinemia
Hypogammaglobulinemia
Immunodeficiency With Hyper-IgM
Wiskott-Aldrich Syndrome

Interventions

BIOLOGICAL: Gammaplex (Intravenous immunoglobulin)

Sponsor

Bio Products Laboratory